July 14, 2022 C-Path’s Dr. Amanda Klein Promoted to Transplant Therapeutic Consortium Executive Director TUCSON, Ariz., July 14, 2022 — Critical Path Institute (C-Path) has named Amanda Klein, Pharm.D., as Executive Director for its
June 30, 2022 Sample Size Calculator for a Surrogate Endpoint in Kidney Transplant Clinical Trials When: Thursday, June 30, 10 a.m. – 12 p.m. ET C-Path’s Transplant Therapeutics Consortium (TTC) invites you to jo
June 30, 2022 Diamyd Medical Joins International Consortium in Type 1 Diabetes TUCSON, Ariz., June 30, 2022 — Diamyd Medical will be a full voting member of the Type 1 Diabetes Consortium (T1DC) led by the U
June 29, 2022 C-Path and Replica Analytics Collaboration Aims to Accelerate Rare Disease Research NEW YORK, OTTAWA and TUCSON, Ariz., June 29, 2022 — Critical Path Institute (C-Path) and Replica Analytics, an Aetion company, a
June 28, 2022 C-Path Welcomes RWS C-Path is proud to welcome RWS as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 28, 2022 C-Path Welcomes Parexel C-Path is proud to welcome Parexel as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consortium. Compri
June 24, 2022 eCOA Consortium Announces Next Article in a Series for Applied Clinical Trials C-Path’s eCOA Consortium is pleased to announce that “Progressing BYOD Adoption” has been published in Applied Clinical Tria
June 22, 2022 C-Path Receives DIA 2022 Americas Inspire Award for Outstanding Contribution to Health TUCSON, Ariz., June 22, 2022 — Critical Path Institute (C-Path) is pleased to announce it has received the DIA 2022 Ameri